Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
Crossref DOI link: https://doi.org/10.1007/s00395-015-0518-1
Published Online: 2015-11-23
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tate, Mitchel
Robinson, Emma
Green, Brian D.
McDermott, Barbara J.
Grieve, David J.
Funding for this research was provided by:
British Heart Foundation (PG/09/102, FS/11/36/28872)
License valid from 2015-11-23